Last update 17 May 2025

TL117

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
TL 117, TL-117
Target
PI3Ks
Action
inhibitors
Mechanism
PI3K family inhibitors(Phosphatidylinositol 3-kinase family inhibitors)
Therapeutic Areas
Neoplasms
Active Indication
Recurrent Squamous Cell Carcinoma of the Head and NeckSquamous cell carcinoma of head and neck metastatic
Inactive Indication-
Originator Organization
Suzhou Junde Biotechnology Co., Ltd.Suzhou Junde Biotechnology Co., Ltd.
Active Organization
Suzhou Junde Biotechnology Co., Ltd.Suzhou Junde Biotechnology Co., Ltd.Suzhou Junde Biotechnology Company, Ltd.Suzhou Junde Biotechnology Company, Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with TL117
CTR20210491
/ RecruitingPhase 1
评价PI3K抑制剂TL117胶囊单药以及联合紫杉醇在复发/转移性头颈部鳞癌患者中的安全性、耐受性、药代动力学特征及初步疗效的I/II期临床试验
[Translation] A phase I/II clinical trial to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of PI3K inhibitor TL117 capsule alone and in combination with paclitaxel in patients with recurrent/metastatic head and neck squamous cell carcinoma
NCT04843098
/ Active, not recruitingPhase 1/2
Phase I/II Study of the PI3K Inhibitor TL117 Alone and in Combination With Paclitaxel in Patients With Relapsed/Metastatic Squamous Cell Carcinoma of the Head and Neck
100 Clinical Results associated with TL117
Login to view more data
100 Translational Medicine associated with TL117
Login to view more data
100 Patents (Medical) associated with TL117
Login to view more data
100 Deals associated with TL117
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Recurrent Squamous Cell Carcinoma of the Head and NeckPhase 2
China
Suzhou Junde Biotechnology Company, Ltd.Suzhou Junde Biotechnology Company, Ltd.
26 May 2021
Squamous cell carcinoma of head and neck metastaticPhase 2
China
Suzhou Junde Biotechnology Company, Ltd.Suzhou Junde Biotechnology Company, Ltd.
26 May 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free